Comparison of Two Norepinephrine Rescue Bolus Doses for Management of Severe Post-Spinal Hypotension During Elective Caesarean Delivery: A Randomized, Controlled Trial
Sarah Amin,Ahmed Hasanin,Nashwa Ghanem,Maha Mostafa,Nashwa Elzayat,Mona Elsherbiny,Yaser Abdelwahab
DOI: https://doi.org/10.2147/ijgm.s446021
IF: 2.145
2024-01-20
International Journal of General Medicine
Abstract:Sarah M Amin, Ahmed Hasanin, Nashwa Talaat Ghanem, Maha Mostafa, Nashwa Elzayat, Mona Elsherbiny, Yaser Abdelwahab Department of Anesthesia and Critical Care Medicine, Cairo University, Cairo, Egypt Correspondence: Ahmed Hasanin, Department of Anesthesia and Critical Care Medicine, Cairo University, Faculty of Medicine, 01 Elsarayah Street, Elmanyal, Cairo, 11559, Egypt, Fax +20224168736, Email Background: Post-spinal hypotension is associated with maternal and neonatal complications; therefore, prompt control maternal blood pressure is necessary. In this study, we aimed to compare the efficacy and safety of two norepinephrine bolus doses in the rescue management of severe maternal hypotension during elective Cesarean delivery. Methods: We included full-term pregnant women scheduled for Cesarean delivery under spinal anesthesia. Patients were randomized to receive either 5-mcg norepinephrine (n=79) or 10-mcg norepinephrine (n=79) for treatment of severe postspinal hypotension (systolic blood pressure ≤ 60% of baseline reading). The management of the hypotensive episode was considered successful if systolic blood pressure was > 80% of the baseline within 2 mins of the bolus. The primary outcome was the incidence of successful management of severe post-spinal hypotension. Secondary outcomes included the incidence of reactive bradycardia, reactive hypertension, umbilical blood gases, and neonatal Apgar score at 5-min post-delivery. Results: We included 73 patients in the 5-mcg group and 76 patients in the 10-mcg group into the final analysis. The incidence of successful management of severe hypotensive episodes was comparable between the two groups (43/73 [59%] and 46/76 [60%] in the 5-and 10-mcg group, respectively, P =0.917). The incidence of reactive hypertension, bradycardia, and neonatal outcomes were comparable between the two groups. Conclusion: In mothers undergoing Cesarean delivery under spinal anesthesia, 10-mcg norepinephrine bolus was not superior to the 5-mcg bolus in the management of severe hypotension. Furthermore, the incidence of reactive bradycardia and hypertension was comparable in the two doses. Clinical Trial Registration: NCT05290740, URL: https://clinicaltrials.gov/ct2/show/NCT05290740 . Keywords: cesarean delivery, spinal anesthesia, severe hypotension, norepinephrine Maternal hypotension after spinal block is associated with maternal and neonatal complications; therefore, it is recommended to use vasopressors, prophylactically and interactively, for prompt control of maternal blood pressure during Cesarean delivery. 1,2 Despite the presence of various preventive regimens (fluid loading, maternal positioning, and vasopressors), many mothers develop postspinal hypotension that requires the use of a vasopressor bolus. 3,4 Severe maternal hypotension, defined as systolic blood pressure ≤60% of the baseline, is a special and critical complication whose incidence reached 7–20%, even while using various protocols for prophylaxis. 3,4 For being a serious and life-threatening condition, it should be promptly managed using an appropriate rescue vasopressor bolus targeting rapid restoration of maternal blood pressure. Norepinephrine is an alpha-adrenergic agonist with weak beta-adrenergic agonistic activity and is increasingly used in obstetric anesthesia with acceptable maternal and neonatal outcomes. 5 Norepinephrine bolus could be used for rapid correction of maternal blood pressure; however, there is no consensus, till date, for the optimum dose. 6–8 Furthermore, no studies focused on the best dose for the management of severe hypotension. A recent report compared 6- and 10-mcg norepinephrine boluses in the management of maternal hypotension and found that both doses had the same success rate (≈90%); however, most of the participants in the mentioned study had non-severe hypotension. 3 Therefore, we hypothesize that severe hypotension should be separately investigated for the possible superiority of the higher over the lower dose of norepinephrine bolus. In this study, we aimed to compare the efficacy and safety of two norepinephrine bolus doses in the rescue management of severe maternal hypotension during elective Cesarean delivery. This randomized controlled, double-blinded study was conducted in Cairo University Hospital after institutional ethics committee approval (MS-657-2021). This study was performed in line with the principles of the Declaration of Helsinki. Written informed consent was obtained from the patient before the enrolment. The trial was registered prior to patient enrollment at clinicaltrials.gov (NCT05290740, Date of registration: 11/03/2022, first posted 22/03/2022). We included full- -Abstract Truncated-
medicine, general & internal